Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/06/2003US6558673 Polypeptide fragment derived from G protein of streptococcus which binds specifically to mammalian serum albumin; immuni-zation
05/06/2003US6558672 Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/06/2003US6558671 Tumor specific immunogens of modified naturally occurring epitope SEQ ID NO:19, 37 or 10
05/06/2003US6558663 Promoting tolerance and inhibiting natural killer cell mediated attack in human recipient to a swine graft
05/06/2003US6558661 Inhibiting binding of interferon-gamma to its native receptor
05/06/2003US6557296 Nucleic acid molecule or fragment thereof that encodes a truncated Nef protein comprising a nucleic acid sequence that encodes substantially the same sequence of amino acid residues 1 through 56 of an HIV-1 Nef protein; treatment of htlv
05/06/2003CA2199830C Expression and export technology of proteins as immunofusins
05/06/2003CA2126691C Gapped 2' modified oligonucleotides
05/06/2003CA2115060C Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
05/06/2003CA2106955C Product and method for improving keratinocyte adhesion to the dermis
05/06/2003CA2101340C Combination of igf-1 and igfbp for anabolism
05/06/2003CA2094144C Methods and applications for efficient genetic suppressor elements
05/06/2003CA2091263C Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
05/06/2003CA2018676C Novel heteropolymeric protein production methods
05/03/2003WO2003022863A1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors
05/02/2003EP1306437A2 Delta opioid receptor genes
05/02/2003EP1306436A1 P53-dependent novel apoptosis-associated protein and method of screening apoptosis controlling agent
05/02/2003EP1306435A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
05/02/2003EP1306434A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
05/02/2003EP1306431A1 Tumor antigen
05/02/2003EP1306385A1 Aequorin as a reporter gene in yeast
05/02/2003EP1306384A1 Aequorin as a growth marker in yeast
05/02/2003EP1306383A1 Method of purifying calcium ion-binding protein
05/02/2003EP1306092A2 Use of GLP-1 and analogs administered peripherally, in regulation of obesity
05/02/2003EP1306091A2 Stimulation of beta cell proliferation
05/02/2003EP1306005A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide
05/02/2003EP1305636A2 Screening method
05/02/2003EP1305634A2 Fluorescence assay for gamma-secretase activity and inhibitors
05/02/2003EP1305633A2 Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof
05/02/2003EP1305627A2 Protein fragment complementation assay based on beta-lactamase
05/02/2003EP1305447A2 Nucleic acids and pathogenic e.coli proteins, and their uses
05/02/2003EP1305438A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s)
05/02/2003EP1305437A2 Expression of biologically active polypeptides in duckweed
05/02/2003EP1305436A2 Co-expression of recombinant proteins
05/02/2003EP1305435A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305423A2 Enhancement of industrial production by increasing substrate transport
05/02/2003EP1305422A2 2,5-dkg permeases
05/02/2003EP1305421A2 Enhanced 2-keto-l-gulonic acid production
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305418A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
05/02/2003EP1305417A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
05/02/2003EP1305416A2 Identification of a novel glutamine transporter
05/02/2003EP1305415A1 Protein inhibitor of apoptosis proteins
05/02/2003EP1305414A2 Modified cea and uses thereof
05/02/2003EP1305412A2 Anthozoa derived chromo/fluoroproteins and methods for using the same
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305406A2 Modulation of gamma-secretase activity
05/02/2003EP1305405A2 Methods of controlling gene expression and gene silencing
05/02/2003EP1305399A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305341A1 Dog melanin-concentrating hormone receptor
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP1305338A2 Modified peptides with increased potency
05/02/2003EP1305337A2 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
05/02/2003EP1305336A2 Therapeutic anti-melanoma compounds
05/02/2003EP1305335A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305331A1 Motor proteins and methods for their use
05/02/2003EP1305039A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
05/02/2003EP1304922A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
05/02/2003EP1304921A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1304920A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1071456B1 Vaccines with an ltb adjuvant
05/02/2003EP1036167B1 Nuclear targeting by means of streptococcal protein h
05/02/2003EP1007675A4 Porcine mhc class i genes and uses thereof
05/02/2003EP0986396A4 Prion protein modulator factor (ppmf) and prion resistant animals
05/02/2003EP0932882B1 Proteome analysis for characterization of up- and down-regulated proteins in biological samples
05/02/2003EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
05/02/2003EP0815130B1 Casein phosphopeptide, casein containing same and process for the preparation thereof
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/02/2003EP0714435B1 Pro-urokinase mutants
05/02/2003EP0700447B1 Fluorescence energy transfer substrates
05/02/2003EP0603216B1 Biocidal proteins
05/02/2003EP0599971B1 Yeast promoter and use thereof
05/01/2003WO2003036546A1 Method of presuming domain linker region of protein
05/01/2003WO2003035892A2 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
05/01/2003WO2003035891A2 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
05/01/2003WO2003035884A2 Transient immortalization
05/01/2003WO2003035883A2 Methods and compositions for inducing tumor-specific cytotoxicity
05/01/2003WO2003035881A2 Stress tolerant plants
05/01/2003WO2003035879A2 Promoters to control cell differentiation
05/01/2003WO2003035873A1 Novel glutamic acid receptor and utilization thereof
05/01/2003WO2003035872A1 Human and mammalian stem cell-derived neuronal survival polypeptides
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035858A2 Bacterial polypeptides involved in nucleic acid processing
05/01/2003WO2003035849A2 Methods for gene transfer using pseudotyped lentiviruses
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035846A2 Structure of tall-1 and its cognate receptor
05/01/2003WO2003035845A2 Salvador tumor suppressor gene
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035837A2 Novel compositions and methods for cancer
05/01/2003WO2003035722A1 Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same
05/01/2003WO2003035698A1 Method for resistance of epilepsy by suppressing the function of alpha 1g protein
05/01/2003WO2003035697A1 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035692A2 Modified peptides and their uses
05/01/2003WO2003035691A1 Apolipoprotein a-i mutation useful for diagnosis and treatment of cardiovascular diseases
1 ... 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 ... 2916